期刊文献+

SELDI-TOF蛋白质谱分析技术在泌尿外科肿瘤诊断中的应用

原文传递
导出
摘要 近年来,针对肿瘤的研究已经不仅仅局限于基因组的研究,而是已经大大扩展到了蛋白质表达分析的层面。蛋白质组学以及相关的技术特别是SELDI技术在泌尿外科方面的应用也仅仅是最近几年间的新进展,仍然有广阔的前景等待开拓。该技术及已经被证明是一种高度敏感以及高通量的质谱分析技术,并且在肿瘤标记物的探索方面已经取得了可喜的成果。本文将介绍SELDI-TOF技术在泌尿外科肿瘤诊断方面的最新应用进展。
出处 《国际泌尿系统杂志》 2007年第4期459-462,共4页 International Journal of Urology and Nephrology
  • 相关文献

参考文献20

  • 1Adam BL, Qu Y, Davis JW, et al. Serum protein fingerprinting coupled with a pattern - matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res, 2002,62 (13) :3609 -3614.
  • 2Ornstein DK,Rayford W,Fusaro VA,et al. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol,2004,172 : 1302 - 1305.
  • 3Ou Y,Adam BL,Yasui Y,et al. Boosted decision tree analysis of surface- enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem,2002,48(10) :1835 - 1843.
  • 4Hlavaty JJ, Partin AW, Kusinitz F,et al. Mass spectroscopy as a discovery tool for identifying serum markers for prostate cancer.Clin Chem,2001,47 : 1924 - 1926.
  • 5Petricoin EF, Omstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst, 2002,94 (20) :1576 - 1578.
  • 6Hlavaty JJ, Partin AW, Shue MJ, et al. Identification and preliminary clinical evaluation of a 50.8 - kDa serum marker for prostate cancer. Urology,2003,61(6) : 1261 - 1265.
  • 7Malik G, Ward MD, Gupta SK, et al. Serum levels of an isoform of apolipoprotein A - Ⅱ as a potential marker for prostate cancer. Clin Cancer Res,2005,11 : 1073 - 1085.
  • 8Le L, Chi K, Tyldesley S, et al. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem,2005,51:695 -707.
  • 9Won Y, Song HJ, Kang TW, et al. Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons. Protcomics ,2003,3:2310 - 2316.
  • 10Hara T, Honda K, Ono M, et al. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry. J Urol,2005 ,174 :1213 - 1217.

二级参考文献13

  • 1Fields S. Proteomics in genomeland. Science, 2001,291:1221-1224.
  • 2Pandey A,Mann M. Proteomics to study genes and genomes. Nature,2000, 405:837-846.
  • 3Sarto C, Frutiger S, Cappellano F, et al. Modified expression of plasma glutathione peroxidase and manganese superoxide dismutase in human renal cell carcinoma. Electrophoresis,1999, 20 :3458-3466.
  • 4Balabanov S, Zimmermann U, Protzel C, et al. Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur J Biochem,2001, 268:5977-5980.
  • 5Klade CS, Voss T, Krystek E, et al. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics, 2001, 1:890-898.
  • 6Ferrari L, Seraglia R, Rossi CR, et al. Protein profiles in sera of patients with malignant cutaneous melanoma. Rapid Commun Mass Spectrom, 2000,14: 1149-1154.
  • 7Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis,2000, 21:1164-1177.
  • 8Bryumor W, Robert S, Shannon B, et al. Detection of early-stage cancer by serum protein analysis. Am Laboratory, 2001,6:32-36.
  • 9von Eggeling F, Davies H, Lomas L, et al. Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques, 2000, 29: 1066-1070.
  • 10Wright GL, Cazares LH, Leung SM,et al. ProteinChip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of biomarker in complex protein mixtures. Prostate Cancer and Prostatic Disease, 20

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部